RE:RE:RE:Lumeda and NSCLC LaserStock29 wrote: I'm sorry Quattro74. Your an idiot. If u think shareholders are gonna buy that pitiful pathetic postulated research and develop garbage forget it. I put out a perfectly good JV partner in Medtronic fully cited it stem to stern and that you need a real global JV to get a global footprint. Stop it now just stop it.
Quattro74 wrote: They have a device it seems and a lung specific dosimetry delivery piece that TLT has yet to develop. We have the PDC
so I'm not worried about their competition. I imagine when TLT is ready to roll out a treatment for NSCLC the dosimetry
part for lungs that will attatch to the TLC-300x device will be developed.
Oh, nevermind you're talking about if TLT delivers their own?? Well Yes I think the Medtronic JV would be a shortcut IF TLT doesn't find something simple to deliver the drugs, like an inhaler, for topical application. That could still happen.